多样性和剂量决定了益生菌SYN-53在过敏犀牛结膜炎中的有效性:一个随机,双盲,安慰剂控制的试验
Karl-Christian Bergmann1,2, Torsten Zuberbier1,2
1Institute of Allergology, Charité Universitätsmedizin, Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität Zu Berlin, Berlin, Germany.
Allergy
|September 11, 2025
概括
多菌株益生菌SYN-53有效地管理过敏犀牛结膜炎 (ARC) 症状. 它的有效性与细菌多样性和剂量直接相关,优于较低剂量或多样性变体.
科学领域:
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
- 胃肠病学 胃肠病学
背景情况:
- 过敏性犀牛结膜炎 (ARC) 显著影响生活质量.
- 多菌株益生菌正在探索用于管理过敏状况.
- 细菌多样性和益生菌剂量的具体贡献仍在研究中.
研究的目的:
- 评估细菌多样性和剂量对SYN-53在ARC管理中的有效性的作用.
- 在一个安慰剂对照试验中,将SYN-53与其低剂量变体 (SYN-53-LD) 和低多样性变体 (SYN-4) 相比较.
主要方法:
- 进行了一项双盲,并行组,安慰剂控制的临床试验.
- 纳入了166名中度至严重草花粉过敏的受试者.
- 参与者接受过敏原暴露室挑战,并每周接受三次SYN-53,SYN-53-LD,SYN-4或安慰剂.
主要成果:
- 与SYN-53-LD (p=0.0372),SYN-4 (p=0.0482) 和安慰剂 (p=0.0329) 相比,SYN-53显著降低了总症状评分 (TSSMAX).
- 与安慰剂相比,SYN-53-LD和SYN-4都没有显著差异 (分别为p=0.7377和p=0.5152).
- 所有干预措施都耐受良好,与安慰剂相比,不良事件没有显著差异.
结论:
- 证实了SYN-53在治疗ARC中的有效性.
- 益生菌的有效性严重依赖于细菌菌株的多样性和所使用的剂量.
- SYN-53代表了ARC的一种可行的治疗选择,通过最佳的菌株多样性和剂量来实现其全部好处.
更多相关视频
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Upper Respiratory Drugs: First and Second-Generation Antihistamines
1.1K
Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
1.1K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
409
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
409
Blinding
3.8K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.8K
Bioavailability Study Design: Single Versus Multiple Dose Studies
217
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
217


